Respiratory Follow-Up After Hospitalization For Covid-19: Who And When?

Marianne Riou,Christophe Marcot,Walid Oulehri,Irina Enache,Cristina Pistea,Eva Chatron,Aissam Labani,Bernard Geny,Mickael Ohana,Frederic De Blay,Romain Kessler,Anne Charloux

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION（2021）

引用 12|浏览7

暂无评分

摘要

Despite more than 148 million infected people, coronavirus disease 2019 (COVID-19) respiratory intermediate and long-term survivors' outcome remains largely unknown. Lungs are the main COVID-19 target organ, and 5-10% patients progress to critical disease including acute respiratory distress syndrome (ARDS) [1]. Pulmonary function tests (PFT) performed at discharge from hospital showed that >80% of severe COVID-19 patients had lung function impairment [2].

查看译文

关键词

COVID-19, respiratory function, respiratory outcome, respiratory sequelae

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要